Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
| Author | |
| Abstract |
:
Boron neutron capture therapy (BNCT) using 4-[10B]boronophenylalanine-fructose (BPA-Fr) is in Phase II clinical trials to validate BNCT as a treatment for glioblastoma multiforme and melanoma. Successful BNCT depends on knowledge of the distribution of boron-containing agents in both tumor and normal tissue as currently determined by chemical confirmation of boron deposition in surgically removed malignant tissue before BNCT. |
| Year of Publication |
:
1997
|
| Journal |
:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
|
| Volume |
:
38
|
| Issue |
:
11
|
| Number of Pages |
:
1762-7
|
| ISSN Number |
:
0161-5505
|
| URL |
:
http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=9374349
|
| Short Title |
:
J Nucl Med
|
| Download citation |
